Blue Cross Blue Shield company Health Care Service Corporation is limiting access for in-office administration of asthma ...

A Nashville infusion therapy company has quietly opened a flurry of D.C.-area locations within the past few months — and intends to bring more to the market this year.

Specialty Infusion Center provides treatment options for certain autoimmune diseases outside of a hospital setting.

The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both ...

“The Triennial is one of the industry’s premier events and is attended by some the largest and most widely respected aquaculture companies in the world,” said Vince Arnone, President and CEO of Fuel ...

The U.S. Food and Drug Administration has approved Datroway (datopotamab deruxtecan-dlnk) for adult patients with ...

The U.S. Food and Drug Administration approved Eisai and Biogen’s application for IV maintenance dosing of lecanemab on January 27. Previously, the label called for biweekly IV dosing. The new ...

CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a ...

Takeda Canada Inc. (Takeda) is pleased to announce that Héma-Québec has added HyQvia®– (normal immunoglobulin [human] 10% and ...

A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.

Given that the treatment involves extensive rehabilitation, ventilator support, and potential physical disability, ...

Discover how groundbreaking research on unique immune cells and advanced AI tools offers renewed hope for improving cancer ...